Contact this trialFirst, we need to learn more about you.
Sodium-glucose cotransporter 2 (SGLT2) inhibitor
Canagliflozin 100 mg +1 More for Type 2 Diabetes
Recruiting1 awardPhase 3
Aurora, Colorado
This trial is testing whether the drug canagliflozin can help control blood sugar levels in people with type 2 diabetes. It also assesses the safety and side effects of the drug.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.